526 related articles for article (PubMed ID: 9564203)
1. The effects of risperidone and olanzapine on the indications for clozapine.
Ganguli R; Brar JS
Psychopharmacol Bull; 1998; 34(1):83-7. PubMed ID: 9564203
[TBL] [Abstract][Full Text] [Related]
2. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
[TBL] [Abstract][Full Text] [Related]
3. Weight gain and antipsychotic medications.
Aquila R; Emanuel M
J Clin Psychiatry; 1999 May; 60(5):336-7. PubMed ID: 10362443
[No Abstract] [Full Text] [Related]
4. Six-month review of weight and metabolic parameters in patients receiving clozapine, risperidone, olanzapine, or quetiapine.
Kelly DL; Kreyenbuhl J; Love RC; Van-Duong Q; Conley RR
J Clin Psychiatry; 2003 Sep; 64(9):1133-4. PubMed ID: 14628994
[No Abstract] [Full Text] [Related]
5. An integrated analysis of acute treatment-emergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: comparisons with placebo, haloperidol, risperidone, or clozapine.
Carlson CD; Cavazzoni PA; Berg PH; Wei H; Beasley CM; Kane JM
J Clin Psychiatry; 2003 Aug; 64(8):898-906. PubMed ID: 12927004
[TBL] [Abstract][Full Text] [Related]
6. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
[TBL] [Abstract][Full Text] [Related]
7. Olanzapine appears haematologically safe in patients who developed blood dyscrasia on clozapine and risperidone.
Dernovsek MZ; Tavcar R
Int Clin Psychopharmacol; 2000 Jul; 15(4):237-8. PubMed ID: 10954065
[TBL] [Abstract][Full Text] [Related]
8. Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.
Atmaca M; Kuloglu M; Tezcan E; Ustundag B
J Clin Psychiatry; 2003 May; 64(5):598-604. PubMed ID: 12755665
[TBL] [Abstract][Full Text] [Related]
9. Comparative effectiveness of antipsychotic drugs.
Meibach RC
Am J Psychiatry; 2003 Mar; 160(3):589-90; author reply 592-3. PubMed ID: 12611851
[No Abstract] [Full Text] [Related]
10. Service use and costs of treating schizophrenia with atypical antipsychotics.
Lewis M; McCrone P; Frangou S
J Clin Psychiatry; 2001 Oct; 62(10):749-56. PubMed ID: 11816863
[TBL] [Abstract][Full Text] [Related]
11. A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder.
Guille C; Sachs GS; Ghaemi SN
J Clin Psychiatry; 2000 Sep; 61(9):638-42. PubMed ID: 11030483
[TBL] [Abstract][Full Text] [Related]
12. Extreme weight gain in a youth with schizophrenia: risk/benefit considerations.
Webster D; Devarajan S; Gallant J; Harris A; Kopala LC
Schizophr Res; 2002 Jul; 56(1-2):187-9. PubMed ID: 12084432
[No Abstract] [Full Text] [Related]
13. Agranulocytosis and neutropenia with typical and atypical neuroleptics.
Hong X; Wang X
Am J Psychiatry; 2001 Oct; 158(10):1736-7. PubMed ID: 11579015
[No Abstract] [Full Text] [Related]
14. Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database.
Gianfrancesco FD; Grogg AL; Mahmoud RA; Wang RH; Nasrallah HA
J Clin Psychiatry; 2002 Oct; 63(10):920-30. PubMed ID: 12416602
[TBL] [Abstract][Full Text] [Related]
15. Atypical neuroleptics in child and adolescent psychiatry.
Remschmidt H; Hennighausen K; Clement HW; Heiser P; Schulz E
Eur Child Adolesc Psychiatry; 2000; 9 Suppl 1():I9-19. PubMed ID: 11140784
[TBL] [Abstract][Full Text] [Related]
16. Glucose intolerance with atypical antipsychotics.
Hedenmalm K; Hägg S; Ståhl M; Mortimer O; Spigset O
Drug Saf; 2002; 25(15):1107-16. PubMed ID: 12452735
[TBL] [Abstract][Full Text] [Related]
17. Weight gain and antipsychotic medication: differences between antipsychotic-free and treatment periods.
Simpson MM; Goetz RR; Devlin MJ; Goetz SA; Walsh BT
J Clin Psychiatry; 2001 Sep; 62(9):694-700. PubMed ID: 11681765
[TBL] [Abstract][Full Text] [Related]
18. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder.
Bilder RM; Goldman RS; Volavka J; Czobor P; Hoptman M; Sheitman B; Lindenmayer JP; Citrome L; McEvoy J; Kunz M; Chakos M; Cooper TB; Horowitz TL; Lieberman JA
Am J Psychiatry; 2002 Jun; 159(6):1018-28. PubMed ID: 12042192
[TBL] [Abstract][Full Text] [Related]
19. Two new atypical antipsychotics: advantages and disadvantages.
Lemon MD
S D J Med; 1998 Aug; 51(8):285-6. PubMed ID: 9724957
[No Abstract] [Full Text] [Related]
20. Novel antipsychotics: comparison of weight gain liabilities.
Wirshing DA; Wirshing WC; Kysar L; Berisford MA; Goldstein D; Pashdag J; Mintz J; Marder SR
J Clin Psychiatry; 1999 Jun; 60(6):358-63. PubMed ID: 10401912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
